190530,74362,{\rtf1\ansi\ansicpg1252\deff0\deflang1033{\fonttbl{\f0\fnil\fcharset0 Times New Roman;}{\f1\froman\fprq2\fcharset0 Times New Roman;}{\f2\fswiss\fprq2\fcharset0 Consolas;}{\f3\fswiss\fcharset0 Consolas;}{\f4\fswiss\fprq2\fcharset0 Calibri;}}
{\colortbl ;\red0\green0\blue255;\red40\green40\blue40;\red255\green255\blue255;}
\viewkind4\uc1\pard\sb240\sa160\sl252\slmult1\qc\lang16393\ul\b\f0\fs40 DEPARTMENT OF MEDICAL ONCOLOGY\fs36\par
\pard\nowidctlpar\sa200\sl276\slmult1\qc\lang9\ulnone\fs28\par
TREATMENT SUMMARY\par
\par
\pard\sa200\sl276\slmult1\qj\kerning2\ul\f1\fs24 FINAL DIAGNOSIS:\line\ulnone\b0 METASTATIC CARCINOMA PROSTATE \line\lang16393 Poorly differentiated neuro endocrine carcinoma\lang9\line\line SYSTEMIC HYPERTENSION ,                                                                                             \line CORONORY ARTERY DISEASE, S/P: PTCA\ul\par
\b DRUG ALLERGY:\line\ulnone\b0 Not known\par
\pard\sb100\sa100\ul\b HISTORY OF PRESENTING ILLNESS:\line\ulnone\b0 Mr. V G Viswanathan, 59-yrs-old male, case of Carcinoma Prostate. He underwent Channel TURP + Bilateral Orchidectomy on 16/05/2018. HPR reported as \lang16393 Acinar Adenocarcinoma, prostate involving 25 - 30% of prostatic tissue, Gleason score 9 (5 + 4) and Perineural invasion present. He developed local symptoms and he received Imagine guided Radiation therapy (5040cGy in 28# to pelvic lymphnode and 70 Gy in 28# to Prostate and seminal vesicle) from 12/06/2018 till 19/07/2018. He was on regular follow up. He presented here on 28/10/2018 with complaints of pleuritic chest pain, exertional breathing difficulty and cough. \lang9 Patient was admitted under Pulmonology for further evaluation and management. He was initiated on symptomatic management and patient got transfered under Medical Oncology. CT chest done showed multiple randomly distributed nodules in bilateral lung fields - suggestive of metastasis, multiple heterodense lesions in both lobes of liver - possibly metastasis, bilateral renal calculi and enlarged AP window mediastinal node. MRI pelvis done showed atrophic hypointense prostate, numerous focal lesions liver, focal lesions vertebra and visualized lungs - consistent with metastases and diffuse edema noted in left inferior pubic ramus? radiation osteitis - metastasis. MRI brain done showed partial empty sella, mild neuroparenchymal atrophy and small vessel ischemic disease. Immunohistochemistry done from TURP regimen was \lang16393 consistent with Poorly differentiated neuro endocrine carcinoma. \lang9 After discussing in detail with the patient relatives, he was initiated on chemotherapy with Carboplatin/Etoposide from 03/11/2018.He is also planned to undergo Inj Zoledronic acid once in 3 months.\line Admitted for cycle \lang16393 6\lang9  chemotherapy. \ul\b\par
\pard\sa200\sl276\slmult1\qj CLINICAL EXAMINATION FINDINGS:\line\ulnone\b0\fs22 ECOG Performance status score: 1\line\lang16393 Vitals stable\line\lang9 No  Pallor, Icterus, Clubbing, Cyanosis, Lymphadenopathy, Pedal Edema\line ORAL CAVITY: Normal\line RESPIRATORY SYSTEM: \lang16393 Rochchi ++\lang9\line CARDIOVASCULAR SYSTEM: S1S2 +\line ABDOMEN: Soft, non distended\line CENTRAL NERVOUS SYSTEM:No FND\par
\pard\ul\b\fs24 INVESTIGATIONS:\lang16393\line\lang3081\kerning0\ulnone\f2\fs20 15-02-2019 07:25 AM\b0\line\b Name                                  Result     Unit         Reference\line\b0 SGPT/ ALT (Serum)                     SubHead                                     \line SGPT                                  18        U/L           30.0 - 65.0\line\b 15-02-2019 07:25 AM\b0\line\b Name                                  Result     Unit         Reference\line\b0 Alkaline Phosphatase                  52        U/L           50.0 - 136.0\line\b 15-02-2019 07:25 AM\b0\line\b Name                                  Result     Unit         Reference\line\b0 Haemoglobin                           10.1      g/dl          13.0 - 17.0         \line TC                                    3.5       x10^3/ul      4.0 - 11.0          \line Differential Count                    SubHead                                     \line Neutrophils                           63        %             40.0 - 80.0         \line Lymphocytes                           25        %             20.0 - 40.0         \line Monocytes                             9         %             2.0 - 10.0          \line Eosinophils                           2         %             1.0 - 6.0           \line Basophils                             1         %             0.0 - 2.0           \line Neutrophils Count                     2.2       x10^3/ul      2.0 - 7.0           \line Lymphocytes Count                     0.9       x10^3/ul      1.0 - 3.0           \line Monocytes Count                       0.3       x10^3/ul      0.2 - 1.0           \line Eosinophils Count                     0.1       x10^3/ul      0.02 - 0.44         \line Basophils Count                       0.0       cells/cumm    0.02 - 0.1          \line RBC Count                             3.4       x10^6/ul      3.8 - 5.3           \line Hct                                   32        %             40.0 - 54.0         \line MCV                                   93        fl            80.0 - 100.0        \line MCH                                   30        pg            27.0 - 32.0         \line MCHC                                  32        g/dl          32.0 - 36.0         \line Platelet                              241       x10^3/ul      150.0 - 450.0       \line RDW                                   17.8      %             10.0 - 16.5         \line MPV                                   8.2       fl            7.5 - 11.5\line\b 15-02-2019 07:25 AM\b0\line\b Name                                  Result     Unit         Reference\line\b0 Renal Function Test                   SubHead                                     \line Urea                                  8         mg/dl         15.0 - 45.0         \line Creatinine                            0.83      mg/dl         0.6 - 1.4\line\b 15-02-2019 07:25 AM\b0\line\b Name                                  Result     Unit         Reference\line\b0 RBS                                   301       mg/dl         70.0 - 160.0\line\kerning2\f3\par
\pard\sa200\sl276\slmult1\qj\lang9\ul\b\f1\fs24 CHEMOTHERAPY GIVEN:\line CYCLE \lang16393 6\lang9  DAY 1 (\lang16393 15\lang9 /0\lang16393 2\lang9 /2019)\line\ulnone\b0 Inj. PALONOSETRON 0.25 mg slow IV bolus over 10 sec\line Inj. DEXONA 4 mg slow IV bolus\line\line Inj. ETOSID (ETOPOSIDE) 170 mg in 500 ml NS over 2 hours\line Inj. KEMOCARB (CARBOPLATIN) 510 mg in \lang16393 500 ml \lang9 5% dextrose over 1 hour\ul\b\par
CYCLE \lang16393 6\lang9  DAY 2-3 (\lang16393 16\lang9 -\lang16393 17\lang9 /02/2019)\line\ulnone\b0 Inj. DEXONA 4 mg slow IV bolus\line\ul\b\line\ulnone\b0 Inj. ETOSID (ETOPOSIDE) 170 mg in 500 ml NS over 2 hours\par
\pard\ul\b COURSE IN THE HOSPITAL:\line\ulnone\b0 Patient admitted for chemotherapy, tolerated it well. Urology consultation was taken for painful micturition and advised to continue same treatment. Urine routine examination was normal. \lang16393 Endocrinology consultation was taken for glycemic control and advice followed. \lang9 He is being discharged in a stable state of health. \line\ul\b\par
\pard\sa200\sl276\slmult1\qj DISCUSSION:\par
\ulnone\b0\fs22 The nature of disease, stage of disease, treatment options, and prognosis were discussed with the patient and family.\par
The expected benefits, possible adverse effects (both temporary and permanent) and approximate expenses associated with the planned chemotherapy was discussed with the patient and relatives by Medical Oncology doctors, before an informed consent was taken from the patient.\par
Chemotherapy was tolerated well during this admission by the patient. No significant adverse effects were encountered. Patient was explained about signs and symptoms of possible delayed adverse effects along with the precautions to be practiced while on chemotherapy and was discharged in a stable condition.\ul\b\fs24\par
DISCHARGE MEDICATIONS:\line\lang16393\ulnone\b0 Tab. PANTOCID 40 mg 1-0-0 x 1 week\lang9\line Cap ABFLO 100 mg 1-0-1 x 3 weeks\line Tab SHELCAL 500 mg 0-1-0 x 3 weeks\line Tab MEGEETRON 40 mg 1-0-1 x 3 weeks\line Tab CLONOTRIL 0.25 mg 0-0-1 x 3 weeks\line Tab SILODAL 8 mg 0-0-1 x 3 weeks\line Tab GERBISA 10 mg 0-0-1 x 3 weeks (Stop in case of loose stools)\line Syp. LOOZ 30 ml 0-0-1 x 3 weeks (Stop in case of loose stools)\line Tab CONTRAMAL DT if needed for pain\line Tab PERINORM 10 mg if needed for vomiting\line Syp. ASCORIL 10 ml 1-1-1 x 3 days\line NEBULIZATION WITH BUDAMATE if needed for breathlessness\par
\fs22 Tab ROSUVOTIN CV 10 mg 0-0-1 (To be continued)\line Tab NEBIGOAL 5 mg 1-0-1 (To be continued)\par
Before leaving your hospital bed, please talk to the nursing staff looking after you and ensure that you have the above medications with you and you understand how to take them after discharge from the hospital.\ul\b\fs24\line\line FOLLOW UP VISIT INSTRUCTIONS:\line\ulnone\b0 To do CBC on \lang16393 25\lang9 /0\lang16393 2\lang9 /2019 and inform\ul\b\line\ulnone\b0\fs22 Next OPD visit on 14/0\lang16393 3\lang9 /2019 with CBC, RFT, SGPT, ALP, RBS and CT chest plain reports. \kerning0\ul\b\f0\fs24\par
\pard\nowidctlpar\sa200\sl276\slmult1\qj\ulnone\b0\fs22 PLEASE MAKE AN APPOINTMENT AND COME TO ONCOLOGY DEPARTMENT with blood test/ scans (if ordered) reports on the above mentioned date.\ul\b\fs24\par
EMERGENCY VISIT INSTRUCTIONS:\par
\ulnone\b0\fs22 In case of emergency or any unexpected problem if you need to see your doctor please report to Rajagiri Emergency department triage with all your medical reports.\par
In event of the following complaints like fever or chills, persistent diarrhoea, vomiting, oral ulcers, difficulty in swallowing, abdominal pain, new skin lesions or bleeding, please report without delay.\ul\b\fs24\par
POST CHEMOTHERAPY INSTRUCTIONS:\par
\ulnone\b0\fs22 1. Ask your doctor any doubts regarding disease and treatment.\par
2. There is no specific diet recommended after chemotherapy.\par
3. Check blood counts in between and SMS your doctor (if requested).\par
4. Do blood investigations prior to next cycle of chemotherapy as requested by your doctor.\par
5. Please inform your regular medications to your doctor.\par
6. Bring day care chemotherapy card with you.\par
7. Avoid over the counter medications/ alternative medicine unless allowed by your doctor.\par
8. If you develop fever more than or equal to \lang16393\fs24 100 F or severe vomiting, tiredness, contact the hospital/ doctor immediately.\par
9. Please have the discharge summary with you when you call your doctor.\par
10. Please note down Emergency numbers:\par
\tab Rajagiri Hospital : 0484- 2905000\line\par
\pard\nowidctlpar\sa200\sl276\slmult1\qc\b "Wish you a speedy recovery"\par
\par
\pard\nowidctlpar\sa200\sl276\slmult1\b0 Name and Signature of Consultant\par
\par
\pard\lang1033\kerning2\b\fs22 Dr. Sanju Cyriac, MD (General Medicine), DM (Medical Oncology), DNB\par
\b0 Consultant - Medical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9747880036\tab\line E-Mail: \cf1\ul sanju.cyriac@rajagirihospital.com <mailto:sanju.cyriac@rajagirihospital.com>\cf0\ulnone\fs21\par
\fs22\par
\b Dr. Subi T. S., MS (General surgery AIIMS, DELHI), MCh (Surgical Oncology, TATA, MUMBAI)\par
\b0 Consultant - Surgical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 8547737149\tab\line E-Mail: \cf1\ul subi.ts@rajagirihospital.com <mailto:subi.ts@rajagirihospital.com>\cf0\ulnone\fs21\par
\ul\fs22\par
\ulnone\b Dr. Varun Rajan MD (Internal Medicine), DM (Medical Oncology)\line\b0 Consultant - Medical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9446805593\par
E-Mail: \cf1\ul varun.rajan@rajagirihospital.com <mailto:varun.rajan@rajagirihospital.com>\cf0\ulnone\par
\pard\qj\line\b Dr. Ayesha Jaleel DMRT DNB\b0\par
\pard Consultant \tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9645884553\par
E-Mail: \cf1\ul ayesha.jaleel@rajagirihospital.com <mailto:rahul.ravind@rajagirihospital.com>\cf0\ulnone\par
 \par
\b Ms. Anooja  Jose\b0\par
Physician Assistant\par
\pard\nowidctlpar\sa200\sl276\slmult1 Rajagiri Hospital\par
\cf2\highlight3\kerning0\b\i\par
Rajagiri Telemedicine Service\b0  - Video Consult with your doctor,\lang16393  \lang1033 from the comfort of your home, using laptop/Mobile and Internet. To book a tele-consult, e-mail to\lang16393  \ul telemedicine@rajagirihospital.com\cf0\highlight0\ulnone\b\i0\f4\par
},<Age:59:Age>,<Sex:1:Sex>,2019-02-17 15:34:34.517000000
